These include whether to expand Medicare/Medicaid coverage of weight-loss meds; new rules for prescribing controlled substances via telehealth; modifications to the No Surprises Act's medical billing dispute system; & FDA's proposed regulations requiring new nutrition labels & banning Red Dye 3.